Next Article in Journal
Risk of Second Primary Thyroid Cancer in Women with Breast Cancer
Next Article in Special Issue
DLBCL 1L—What to Expect beyond R-CHOP?
Previous Article in Journal
Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review
 
 
Review

Article Versions Notes

Cancers 2022, 14(4), 956; https://doi.org/10.3390/cancers14040956
Action Date Notes Link
article xml file uploaded 15 February 2022 09:12 CET Original file -
article xml uploaded. 15 February 2022 09:12 CET Update https://www.mdpi.com/2072-6694/14/4/956/xml
article pdf uploaded. 15 February 2022 09:12 CET Version of Record https://www.mdpi.com/2072-6694/14/4/956/pdf
article html file updated 15 February 2022 09:13 CET Original file -
article html file updated 31 July 2022 18:13 CEST Update https://www.mdpi.com/2072-6694/14/4/956/html
Back to TopTop